PL3790957T3 - Sposób wytwarzania populacji hmpc w warunkach wolnych od składników ksenogenicznych - Google Patents
Sposób wytwarzania populacji hmpc w warunkach wolnych od składników ksenogenicznychInfo
- Publication number
- PL3790957T3 PL3790957T3 PL19723059.2T PL19723059T PL3790957T3 PL 3790957 T3 PL3790957 T3 PL 3790957T3 PL 19723059 T PL19723059 T PL 19723059T PL 3790957 T3 PL3790957 T3 PL 3790957T3
- Authority
- PL
- Poland
- Prior art keywords
- hmpc
- xeno
- population
- free generation
- generation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0031—Serum-free culture media
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/98—Xeno-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Virology (AREA)
- Vascular Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18171162 | 2018-05-08 | ||
| PCT/EP2019/061561 WO2019215090A1 (en) | 2018-05-08 | 2019-05-06 | Method for xeno-free generation of a population of hmpc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3790957T3 true PL3790957T3 (pl) | 2026-05-04 |
Family
ID=62142966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19723059.2T PL3790957T3 (pl) | 2018-05-08 | 2019-05-06 | Sposób wytwarzania populacji hmpc w warunkach wolnych od składników ksenogenicznych |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US12370221B2 (pl) |
| EP (2) | EP3790957B1 (pl) |
| JP (2) | JP2021522805A (pl) |
| KR (1) | KR102906924B1 (pl) |
| AU (1) | AU2019266916B2 (pl) |
| BR (1) | BR112020022667A2 (pl) |
| CA (1) | CA3098775A1 (pl) |
| DK (1) | DK3790957T3 (pl) |
| ES (1) | ES3066815T3 (pl) |
| FI (1) | FI3790957T3 (pl) |
| HR (1) | HRP20260408T1 (pl) |
| IL (1) | IL287353A (pl) |
| LT (1) | LT3790957T (pl) |
| MX (1) | MX2020011884A (pl) |
| PL (1) | PL3790957T3 (pl) |
| PT (1) | PT3790957T (pl) |
| RS (1) | RS67908B1 (pl) |
| SI (1) | SI3790957T1 (pl) |
| SM (1) | SMT202600150T1 (pl) |
| WO (1) | WO2019215090A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023217129A1 (zh) * | 2022-05-10 | 2023-11-16 | 上海赛立维生物科技有限公司 | 肝内胆管前体样细胞、细胞制剂及制备方法和应用 |
| JP2024010789A (ja) * | 2022-07-13 | 2024-01-25 | 株式会社日立製作所 | 加速器及び粒子線治療システム |
| JP2025529176A (ja) | 2022-09-02 | 2025-09-04 | ウニベルシタット チューリッヒ | 注射装置 |
| EP4600350A1 (en) * | 2022-10-03 | 2025-08-13 | Kidswell Bio Corporation | Novel dental pulp stem cell population |
| WO2024075145A1 (ja) * | 2022-10-03 | 2024-04-11 | キッズウェル・バイオ株式会社 | 新規な歯髄幹細胞集団 |
| EP4627056A1 (en) | 2022-12-01 | 2025-10-08 | Universität Zürich | Method of preparing a mass culture of muscle precursor cells (mpcs) and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5130141A (en) | 1988-05-24 | 1992-07-14 | Law Peter K | Compositions for and methods of treating muscle degeneration and weakness |
| ES2678416T3 (es) * | 2007-01-11 | 2018-08-10 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Células derivadas de músculo para el tratamiento de patologías de las vías urinarias y métodos de fabricación y uso de las mismas |
| US20140227233A1 (en) | 2013-01-29 | 2014-08-14 | University Hospitals Cleveland Medical Center | Treatment of Urinary Incontinence with Regenerative Glue |
| WO2016138289A1 (en) | 2015-02-27 | 2016-09-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of generating cells of the smooth muscle lineage and uses thereof |
-
2019
- 2019-05-06 PL PL19723059.2T patent/PL3790957T3/pl unknown
- 2019-05-06 MX MX2020011884A patent/MX2020011884A/es unknown
- 2019-05-06 FI FIEP19723059.2T patent/FI3790957T3/fi active
- 2019-05-06 WO PCT/EP2019/061561 patent/WO2019215090A1/en not_active Ceased
- 2019-05-06 CA CA3098775A patent/CA3098775A1/en active Pending
- 2019-05-06 HR HRP20260408TT patent/HRP20260408T1/hr unknown
- 2019-05-06 EP EP19723059.2A patent/EP3790957B1/en active Active
- 2019-05-06 ES ES19723059T patent/ES3066815T3/es active Active
- 2019-05-06 BR BR112020022667-0A patent/BR112020022667A2/pt unknown
- 2019-05-06 RS RS20260355A patent/RS67908B1/sr unknown
- 2019-05-06 SM SM20260150T patent/SMT202600150T1/it unknown
- 2019-05-06 LT LTEPPCT/EP2019/061561T patent/LT3790957T/lt unknown
- 2019-05-06 KR KR1020207034490A patent/KR102906924B1/ko active Active
- 2019-05-06 SI SI201931040T patent/SI3790957T1/sl unknown
- 2019-05-06 AU AU2019266916A patent/AU2019266916B2/en active Active
- 2019-05-06 US US17/049,397 patent/US12370221B2/en active Active
- 2019-05-06 PT PT197230592T patent/PT3790957T/pt unknown
- 2019-05-06 DK DK19723059.2T patent/DK3790957T3/da active
- 2019-05-06 JP JP2020562575A patent/JP2021522805A/ja active Pending
- 2019-05-06 EP EP25225594.8A patent/EP4699656A3/en active Pending
-
2021
- 2021-10-18 IL IL287353A patent/IL287353A/en unknown
-
2023
- 2023-12-08 JP JP2023207408A patent/JP2024028920A/ja active Pending
-
2025
- 2025-06-26 US US19/250,774 patent/US20250319138A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR102906924B1 (ko) | 2025-12-31 |
| DK3790957T3 (da) | 2026-03-30 |
| JP2024028920A (ja) | 2024-03-05 |
| FI3790957T3 (fi) | 2026-03-23 |
| JP2021522805A (ja) | 2021-09-02 |
| EP3790957A1 (en) | 2021-03-17 |
| CA3098775A1 (en) | 2019-11-14 |
| HRP20260408T1 (hr) | 2026-05-22 |
| WO2019215090A1 (en) | 2019-11-14 |
| IL287353A (en) | 2021-12-01 |
| ES3066815T3 (en) | 2026-05-18 |
| AU2019266916B2 (en) | 2025-05-22 |
| SI3790957T1 (sl) | 2026-05-29 |
| US20250319138A1 (en) | 2025-10-16 |
| SMT202600150T1 (it) | 2026-05-12 |
| BR112020022667A2 (pt) | 2021-02-09 |
| RS67908B1 (sr) | 2026-04-30 |
| US20210244770A1 (en) | 2021-08-12 |
| MX2020011884A (es) | 2021-01-20 |
| PT3790957T (pt) | 2026-03-26 |
| EP3790957B1 (en) | 2025-12-31 |
| EP4699656A3 (en) | 2026-07-15 |
| LT3790957T (lt) | 2026-04-10 |
| KR20210008009A (ko) | 2021-01-20 |
| EP4699656A2 (en) | 2026-02-25 |
| AU2019266916A1 (en) | 2020-10-22 |
| US12370221B2 (en) | 2025-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL287353A (en) | A method for generating a xeno-free population of hmpc | |
| IL276597A (en) | A method for producing a low antigenic cell | |
| IL277008A (en) | Create a spray | |
| IL278865A (en) | Create a spray | |
| GB201915444D0 (en) | Method of using a blockchain | |
| GB201812498D0 (en) | Aerosol generation | |
| IL280093A (en) | Create a spray | |
| SG10201910623VA (en) | Wafer producing method | |
| GB201812497D0 (en) | Aerosol generation | |
| HUE064016T2 (hu) | Eljárás LGPS-alapú szilárd elektrolit elõállítására | |
| GB201812509D0 (en) | Aerosol generation | |
| GB201812500D0 (en) | Aerosol generation | |
| IL280023A (en) | Create a spray | |
| GB201812507D0 (en) | aerosol generation | |
| PL3604216T3 (pl) | Sposób wytwarzania stałego elektrolitu zawierającego Li<sub>3</sub>PS<sub>4</sub> | |
| GB201812502D0 (en) | Aerosol generation | |
| GB201812510D0 (en) | Aerosol generation | |
| PL3605703T3 (pl) | Sposób wytwarzania elektrolitu stałego na bazie lgps | |
| GB201812494D0 (en) | Aerosol generation | |
| SG11202100829SA (en) | Method for producing cd3-positive cell | |
| SG11202105311VA (en) | Method of identifying a structure | |
| IL277467A (en) | A method for producing natural killer cells | |
| SI3741701T1 (sl) | Postopek za izdelavo kovinskega pokrova pločevinke | |
| GB201812505D0 (en) | Aerosol generation | |
| GB201812508D0 (en) | Aerosol generation |